CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice
Andrology · 2025
DOI: 10.1111/andr.13564 ↗At a glance
Journal article in Andrology, 2025. Written by Yo Ogawa and 4 co-authors. Institution: Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan. Major MEDLINE topics: Testis, Fertility, CRISPR-Cas Systems, Gene Editing. Cited 6 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: NICHD NIH HHS, Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (original language)
Background
Mammalian fertilization is mediated by multiple sperm acrosomal proteins, many of which are testis‐enriched transmembrane glycoproteins expressed during spermiogenesis (e.g., Izumo sperm‐egg fusion 1, Sperm acrosome associated 6, and Transmembrane protein 95).
Methods
We hypothesized that proteins with these features might have a role in sperm–egg interaction and thus carried out an in‐silico screen based on multiple public databases. We generated knockout mouse lines lacking seven candidate proteins by the CRISPR/Cas9 system and conducted detailed analyses on the fecundity of the knockout males, as well as their testis appearance and weight, testis and epididymis histology, and sperm motility and morphology.
Results
Through the in‐silico screen, we identified 4932438H23Rik, A disintegrin and metalloproteinase domain‐containing protein 29, SAYSvFN domain‐containing protein 1, Sel‐1 suppressor of lin‐12‐like 2 ( C. elegans ), Testis‐expressed protein 2, Transmembrane and immunoglobulin domain‐containing 3, and Zinc and ring finger 4. Phenotypic analyses unveiled that the knockout males showed normal testis gross appearance, normal testis and epididymis histology, and normal sperm morphology and motility. Fertility tests further indicated that the knockout male mice could sire pups with normal litter sizes when paired with wild‐type females. Discussion and conclusion These findings suggest that these seven proteins are individually dispensable for male reproduction and fertilization. Future studies are warranted to devise advanced in‐silico screening approaches that permit effective identification of gamete fusion‐required sperm proteins.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
- Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
- Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University, Suita, Japan.
- Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
- Graduate School of Medicine, Osaka University, Suita, Japan.
- The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID profiles: Yonggang Lu, Daiji Kiyozumi, Masahito Ikawa
Funding
- NICHD NIH HHS
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Gates Foundation
- Bill and Melinda Gates Foundation
Cite
APA
Ogawa, Y., Lu, Y., Kiyozumi, D., Chang, H. Y., & Ikawa, M. (2025). CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice. Andrology. https://doi.org/10.1111/andr.13564
Vancouver
Ogawa Y, Lu Y, Kiyozumi D, Chang HY, Ikawa M. CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice. Andrology. 2025. doi:10.1111/andr.13564
BibTeX
@article{Ogawa2025,
author = {Ogawa, Yo and Lu, Yonggang and Kiyozumi, Daiji and Chang, Hsin-Yi and Ikawa, Masahito},
title = {CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice},
journal = {Andrology},
year = {2025},
doi = {10.1111/andr.13564}
}
EUVIMED